Journal
ANNALS OF THORACIC SURGERY
Volume 111, Issue 3, Pages e183-e184Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.athoracsur.2020.08.003
Keywords
-
Ask authors/readers for more resources
Patients with severe COVID-19 are prone to a strong inflammatory response and thrombotic complications. Pulmonary vein thrombosis, while rare, can lead to pulmonary congestion, infarction, and potentially mortality. This case report highlights the development of hemorrhagic infarction in a COVID-19 patient requiring ECMO, due to inferior vein thrombosis and subsequent lobectomy.
Patients with severe coronavirus disease 2019 from infection with severe acute respiratory syndrome coronavirus 2 mount a profound inflammatory response and are predisposed to thrombotic complications. Pulmonary vein thrombosis is a rare disease process resulting in pulmonary congestion, infarction, and potential mortality. This report describes a patient with coronavirus disease 2019 requiring venovenous extracorporeal membrane oxygenation for hypoxic respiratory failure who developed hemorrhagic infarction of the right lower lobe. During emergency exploration the patient was found to have a right inferior vein thrombosis and marked lobar hemorrhage mandating lobectomy. (C) 2021 by The Society of Thoracic Surgeons
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available